312443
Do Insurance Mandates Reduce Racial Disparities in Colorectal Cancer Screening?
Methods: Using a sample of insured individuals age 51 to 64 (n = 286,930) from Behavioral Risk Factor Surveillance System (BRFSS) data, we estimate a logistic Difference in Difference regression of up-to-date screening on mandate enactment, race/ethnicity categorical variables, and interactions using a non-mandate state control group.
Results: We find substantial reductions in screening disparities. Disparities in up-to-date screening between Native Hawaiians/Pacific Islanders and whites were eliminated after mandates (pre-mandate OR = 0.64, post OR = 1.26, χ2 p=0.00). Differences between Asians and whites also fell (pre OR = 0.75, post OR = 0.82, χ2 p=0.00) Although we found no change in up-to-date disparities for blacks, the black-white endoscopic screening disparity decreased significantly (pre OR = 0.87, post OR = 0.98, χ2 p=0.04)
Conclusions: We conclude mandates did reduce racial/ethnic disparities in CRC screening, which implies differences in insurance coverage do contribute to disparities. Our findings also imply PPACA mandates may further reduce disparities, depending on the racial and ethnic distribution of grandfathered plans.
Learning Areas:
Biostatistics, economicsChronic disease management and prevention
Diversity and culture
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Social and behavioral sciences
Learning Objectives:
Describe racial and ethnic disparities in colorectal cancer screening. Explain how insurance mandates may importantly reduce disparities even if they have limited effects on aggregate screening behavior. Explain the importance of exogenous policy variation in empirical studies of socioeconomic determinants of healthcare consumption. Assess the likely impact of PPACA mandates on remaining racial and ethnic disparities.
Keyword(s): Cancer Prevention and Screening, Minority Health
Qualified on the content I am responsible for because: I am a PhD health economist with advanced training in the statistical methods applied in this paper. I have previously published work on preventive care in peer reviewed journals and my coauthor and I have been studying colorectal cancer screening in particular for several years now. This paper is not under review yet, but we have just responded to a revision request at Health Economics for a similar paper.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.